FENC

Fennec Pharmaceuticals (FENC)

About Fennec Pharmaceuticals (FENC)

Fennec Pharmaceuticals, Inc. is a specialty pharmaceutical company. It focuses on the development and commercialization of PEDMARK to reduce the risk of platinum-induced ototoxicity in pediatric patients. The company was founded by Orest W. Blaschuk on September 3, 1996 and is headquartered in Durham, NC.

Details

Daily high

$6.97

Daily low

$6.02

Price at open

$6.16

52 Week High

$9.92

52 Week Low

$4.68

Market cap

254.3M

Dividend yield

0.00%

Volume

544,881

Avg. volume

168,207

P/E ratio

-31.30

Fennec Pharmaceuticals News